Dividends Calendar Earnings Calendar
CARA

CARA | Cara Therapeutics

Cara Therapeutics
Category: Biotechnology company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Stamford, Connecticut, United States

Trade prices

  • Volume:
  • Market Cap: 638.83M
  • Prev closed: 21.75
  • Open: 22.16
  • High: 23.89
  • Low: 22.05
  • 52 week low: 11.94
  • 52 week high: 23.89
  • Dividends:No Dividends

Next ER: February 24, 2022 



Top Stories (CARA)

    Company Profile

    Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs).

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    March 10, 2022
    November 8, 2021-0.02 / -0.386320.27M / 15.59MBeat!
    August 9, 2021-0.61 / -0.5483- / -
    May 10, 2021-0.47 / -0.57331.94M / 3.03M
    February 25, 20211.59 / 0.3643112.09M / 5.98MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jan 19, 2022 12.12 11.68
    12.14
    11.63
    159.62K 5.03%
    Jan 18, 2022 11.54 11.85
    11.97
    11.52
    409.86K -3.43%
    Jan 14, 2022 11.95 11.70
    11.99
    11.58
    307.42K 2.58%
    Jan 13, 2022 11.65 11.89
    12.01
    11.61
    271.92K -2.35%
    Jan 12, 2022 11.93 12.33
    12.36
    11.91
    245.51K -2.93%
    Jan 11, 2022 12.29 11.99
    12.37
    11.99
    348.25K 1.32%
    Jan 10, 2022 12.13 11.76
    12.16
    11.53
    495.85K 3.15%
    Jan 7, 2022 11.76 11.73
    11.98
    11.62
    431.89K 0.86%
    Jan 6, 2022 11.66 11.70
    11.93
    11.50
    301.81K -0.09%
    Jan 5, 2022 11.67 12.49
    12.65
    11.65
    515.86K -6.49%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2004
    • Employees:80

    News

    News for (CARA)

    This company doesn't provide a dividend.


    Talk about Cara Therapeutics below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Feb 24, 2022 (Same day)

    adsk hpq crm fslr bby w rmax vale swn edit int vmw 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    LinkedIn

    Peers / Similar stocks 

    jnj xlv pfe 

    Other stocks 

    csco pg hpq aap mik hrl dnow lrcx pfe mdt omc gsat 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet